Bacos Anthony 4
4 · Stitch Fix, Inc. · Filed Jul 8, 2026
Research Summary
AI-generated summary of this filing
Stitch Fix (SFIX) CTO Anthony Bacos Exercises Options, Sells Shares
What Happened Anthony Bacos, Chief Product & Technology Officer at Stitch Fix, exercised stock derivatives and sold shares on July 6, 2026. He exercised 50,000 shares at $2.48 per share (total cost $124,000) and another 50,000 shares reported as a conversion/exercise with $0 cash consideration. Separately, he sold 50,000 shares (weighted avg $3.80; proceeds $189,825) and 20,000 shares (weighted avg $3.76; proceeds $75,264) in open-market transactions, for combined sale proceeds of about $265,089. The sales were executed under a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction date: July 6, 2026; Form 4 filed July 8, 2026 (appears timely).
- Exercise/acquisition: 50,000 shares at $2.48 = $124,000.
- Conversion/exercise: 50,000 shares @ $0.00 reported (no cash consideration reported).
- Open-market sales: 50,000 shares at weighted avg $3.80 (proceeds $189,825); 20,000 shares at weighted avg $3.76 (proceeds $75,264). Total sale proceeds ≈ $265,089.
- Weighted-price ranges: 50k-sale prices ranged $3.705–$3.845 (footnote F2); 20k-sale prices ranged $3.71–$3.84 (footnote F3). Reporting person can provide breakdowns on request.
- Sale plan: Sales pursuant to a Rule 10b5-1 plan entered March 17, 2026 (footnote F1).
- Vesting note: Option vesting schedule described in filing (footnote F4).
- Shares owned after transaction: Not provided in the data supplied here; see the Form 4 for post-transaction holdings.
Context This filing shows an option/derivative exercise plus immediate open-market sales. The combination of exercising options and selling shares is commonly a routine liquidity action for insiders; the sales here were executed under a 10b5-1 plan, which schedules trades in advance. The Form 4 reports a conversion/exercise with $0 cash consideration for 50,000 shares but does not explain the mechanics — check the full filing for details.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-07-06$2.48/sh+50,000$124,000→ 1,101,994 total - Sale
Class A Common Stock
[F1][F2]2026-07-06$3.80/sh−50,000$189,825→ 1,051,994 total - Sale
Class A Common Stock
[F1][F3]2026-07-06$3.76/sh−20,000$75,264→ 1,031,994 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F1][F4]2026-07-06−50,000→ 522,543 totalExercise: $2.48Exp: 2034-04-01→ Class A Common Stock (50,000 underlying)
Footnotes (4)
- [F1]This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026.
- [F2]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.705 to $3.845 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.71 to $3.84 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.